First Report on UK Database of Haemophilia B Mutations and Pedigrees

Summary

In order to obtain complete success in the carrier and prenatal diagnoses required for genetic counselling in haemophilia B a new strategy is being implemented in the UK. This entails the construction of a national confidential database of mutations, pedigrees and haema- tological data. This will allow the inefficient indirect tests based on the analysis of DNA polymorphisms to be abandoned and direct detection of the gene defect to be used instead. After two and a half years of nationwide collaboration, 702 samples have been collected from 313 families, representing more than half of the UK haemophilia B families, and 217 mutations have been characterised. The 141 diagnostic tests so far performed have clearly indicated that the new strategy not only allows virtually 100% diagnostic success, but also rapid results. This work on haemophilia B may represent a model for other diseases with high mutational heterogeneity.

• References

• 1 Giannelli F, Saad S, Montandon AJ, Bentley DR, Green PM. A new strategy for the genetic counselling of diseases of marked mutational heterogeneity: haemophilia B as a model. Journal of Medical Genetics 1992; 29: 602-7
• 2 Green PM, Bentley DR, Mibashan RS, Nilsson IM, Giannelli F. Molecular pathology of haemophilia B. EMBO Journal 1989; 8: 1067-1072
• 3 Montandon AJ, Green PM, Giannelli F, Bentley DR. Direct detection of point mutations by mismatch analysis: application to haemophilia B. Nucleic Acids Research. 1989; 17: 3347-3358
• 4 Naylor JA, Green PM, Montandon JA, Rizza CR, Giannelli F. Detection of three novel mutations in two haemophilia A patients by rapid screening ot whole essential regions of factor VIII gene. Lancet 1991; 337: 635-639
• 5 Montandon AJ, Green PM, Bentley DR, Ljung R, Nilsson IM, Giannelli F. A new strategy for carrier prenatal diagnosis and molecular studies in haemophilia B. In: Biotechnology of plasma proteins. Current Studies in Hematology and Blood Transfusion. Albertini A, Lenfant CL, Mannucci PM, Sixma JJ. (eds) Basel: Karger. 1991. (; 58). 88-93
• 6 Van Essen AJ, Abbs S, Baiget M. et al. Parental origin and germline mosaicism ol deletions and duplications of the dystrophin gene: a European study. Human Genetics 1992; 88: 249-57
• 7 Montandon AJ, Green PM, Bentley DR, Ljung R, Kling S, Nilsson IM, Giannelli F. Direct estimate of the haemophilia B (factor IX deficiency) mutation rate and of the ratio of the sex-specific mutation rates in Sweden. Human Genetics 1992; 89: 319-22
• 8 Austen DEG, Rhymes IL. A laboratory manual of blood coagulation. Oxford Blackwell Scientific. 1975
• 9 Anson DS, Austen DEG, Brownlee GG. Expression of active human clotting factor IX from recombinant DNA clones in mammalian cells. Nature (London) 1985; 315: 683-5
• 10 Giannelli F, Choo KH, Rees DJG, Boyd Y, Rizza CR, Brownlee GG. Gene deletions in patients with haemophilia B and anti factor IX antibodies. Nature (London) 1983; 303: 181-182
• 11 Green PM, Bentley DR, Mibashan RS, Giannelli F. Partial deletion by illegitimate recombination of the factor IX gene in a haemophilia B family with two inhibitor patients. Molecular Biology and Medicine 1988; 5: 95-106
• 12 Crossley M, Brownlee GG. Disruption of a C/EBP binding site in the factor IX promoter is associated with hemophilia B. Nature (London) 1990; 345: 444-446
• 13 Crossley M, Ludwig M, Stowell KM, De Vos P, Olek K, Brownlee GG. Recovery from haemophilia B Leyden: An androgen-responsive element in the factor IX promoter. Science 1992; 257: 377-379
• 14 Giannelli F, Green PM, High KA, Sommer S, Poon MC, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Brownlee GG. Haemophilia B: database of point mutations and short additions and deletions – fourth edition 1993. Nucleic Acids Research 1993; 21: 3075-3087
• 15 Crossley M, Winship PR, Austen DEG, Rizza CR, Brownlee GG. A less severe form of haemophilia B Leyden. Nucleic Acids Research 1990; 18: 4633
• 16 Green PM, Montandon AJ, Ljung R, Bentley DR, Nilsson IM, Kling S, Giannelli F. Haemophilia B mutations in a complete Swedish population sample: A test of new strategy for the genetic counselling of diseases with high mutational heterogeneity. British Journal of Haematology 1991; 78: 390-397
• 17 Green PM, Montandon AJ, Bentley DR, Giannelli F. Genetics and molecular biology of haemophilias A and B. Blood Coagulation and Fibrinolysis 1991; 2: 539-65
• 18 Taylor SAM, Deugau KV, Lillicrap DP. Somatic mosaicism and female-to- female transmission in a kindred. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 39-12
• 19 Handford PA, Baron M, Mayhew M, Willis A, Beesley T, Brownlee GG, Campbell ID. The first EGF-like domain from human factor IX contains a high-affinity calcium binding site. EMBO Journal 1990; 9: 475-480
• 20 Titani K, Fujikawa K. The structural aspects of vitamin K-dependent blood coagulation factors. Acta Haematologica Japonica 1982; 45: 807-816
• 21 Knoblah O, Zoll B, Zerres K, Brackman HH, Olek K, Ludwig M. Recurrent mutations in the factor IX gene: founder effect or repeat de novo events. Investigation of the German haemophilia B population and review of de novo mutations. Human Genetics 1993; 92: 40-48
• 22 Thompson AR, Schoof JM, Weinmann AF, Chen SH. Factor IX mutations: rapid direct screening methods for 20 new families with haemophilia B. Thromb Haemost 1992; 65: 289-295
• 23 Tartary M, Vidaud D, Piao Y, Costa JM, Bahnouk BR, Fressinaud E, Congard B, Laurian Y, Meyer D, Lavergne JM, Vidaud M. Detection of a molecular defect in 40 of 44 patients with haemophilia B by PCR and denaturing gradient gel electrophoresis. British Journal of Haematology 1993; 84: 662-669
• 24 Gostaut B, Vielhaber E, Ketterling R, Yoon HS, Bottema CDK, Kasper CK, Kucipei MA. Suiimiei 3S. Geiniline mutations in the factor IX gene: a comparison of the pattern in Caucasians and non-Caucasians. Human Molecular Genetics 1993; 2: 293-8
• 25 Lin SW, Shen MC. Genetic basis and carrier detection of hemophilia R of Chinese origin. Thromb Haemost 1993; 69: 247-252
• 26 Ghanem N, Costes B, Martin J, Vidaud M, Rothschild C, Foyer-Gazengal C, Goossens M. Twenty-four novel hemophilia B mutations revealed by rapid scanning of the whole factor IX gene in a French population sample. European Journal of Human Genetics 1993; 1: 144-155
• 27 Poon MC, Anand S, Fraser BM, Hoar DI, Sinclair DG. Haemophilia B carrier determination based on family-specific mutation detection by DNA single-strand conformation analysis. Journal of Laboratory and Clinical Medicine 1993; 122: 55-63
• 28 Green PM, Montandon AJ, Bentley DR, Ljung R, Nilsson IM, Giannelli F. The incidence and distribution of CpG→TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots. Nucleic Acids Research 1990; 18: 3227-3231
• 29 O’Hara PJ, Grant FJ, Haldman BA, Gray CL, Insley MY, Hagen FS, Murray MJ. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proceedings of the National Academy of Sciences of the United States of America 1987; 84: 5158-62
• 30 Sarkar G, Koeberl DD, Sommer SS. Direct sequencing of the activation peptide and the catalytic domain of the factor IX gene in six species. Genomics 1990; 6: 133-145
• 31 Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry 1985; 24: 3736-50